Kenya Type II Diabetes Mellitus Market Analysis


  • Type: Common Disease Area
  • Published : June 2021
  • Region: Africa
  • Country: Kenya
  • Report ID : 4840

  • Format: PPT, PDF

Kenya Type Ⅱ Diabetes Mellitus Drug Market: Segmented by Drug Class (Biguanides, Sulfonylureas, Meglitinides and glucagon-like peptide-1 (GLP-1) receptor agonists, D-Phenylalanine Derivatives, Thiazolidinediones, DPP-4 Inhibitors, Alpha-glucosidase Inhibitors, and Others), Route of Administration (Oral and Injectable) and Distribution Channel ( Hospital Pharmacies, Retail Pharmacies and Online Pharmacies) – Growth, Trends, and Forecasts (2019 – 2028)

SKU: 4840 Categories: ,

Report Overview

The Type Diabetes Mellitus drug market size in Kenya stood at USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period

TypeⅡ Diabetes Mellitus also known as Non-Insulin Dependent Diabetes Mellitus refers to a defect in insulin secretion and sensitivity, whereby the β-cells in the pancreas fail to secrete sufficient amounts of insulin and cells fail to uptake adequate amounts of insulin due to loss of sensitivity, commonly referred to as insulin resistance. The World Health Organization (WHO) estimates that the prevalence of Diabetes Mellitus in Kenya at 3.3% and predicts a rise to 4.5% by 2025. However, two-thirds of diabetics may be undiagnosed. Higher rates of diabetics are found in urban areas. Urbanisation and adoption of ‘Western lifestyles’ have led many Kenyans towards risk for developing DM. Kenya has seen increase in the risk factors like abdominal obesity, poor dietary habits, excess alcohol consumption, smoking and physical inactivity.

Market Drivers

The market is majorly driven by the increasing prevalence of Type Ⅱ Diabetes Mellitus in Kenya. The Prevalence of type Ⅱ diabetes mellitus is 16%  which is high for a rural community in Kenya where majority live on ≤ 1 dollar/day.  About 1% of deaths in Kenya were directly attributable to Type Ⅱ Diabetes Mellitus in 2012.

Increasing initiatives by Government of Kenya by Implementation of National Diabetes Mellitus Strategy in 2015 has led to establishment of hospital Diabetes clinics in nine provinces of the country. A Diabetes Education Programme has also been implemented for healthcare staff.

Overall, Rise in the prevalence of TypeⅡDiabetes Mellitus, Increased partnerships by private pharmaceutical companies like Sanofi and Novo Nordisk with the Ministry of Health, Kenya and increase in the healthcare expenditure are fuelling growth in Type Ⅱ Diabetes Mellitus treatment market in Kenya.

Diabetes Mellitus requires long-term follow up, with uninterrupted access to medication and specialist care. Low levels of public awareness, high cost of Insulin, non-adherence to treatment, poor behaviours towards Diabetes Mellitus and unwillingness to adopt healthier lifestyles are hindering growth of market.


1. Kenya Type Ⅱ Diabetes Mellitus Drug Market Overview………………………….
A. Market Size
2. Market Growth Drivers………………………………………………………………
A. Increase in the Prevalence of Type Ⅱ Diabetes Mellitus in Kenya
B. Implementation of National Diabetes Strategy and Other Government Initiatives to Control and Manage Type Ⅱ Diabetes Mellitus and Related Complications
3. Epidemiology…………………………………………………………………………….
A. Prevalence of TypeⅡDiabetes Mellitus.
B. Incidence of TypeⅡDiabetes Mellitus.
4. Type Ⅱ Diabetes Mellitus Market Segmentation……………………………………
A. Drug Class
I. Biguanides
II. Sulfonylureas
III. Meglitinides and D-Phenylalanine Derivatives
IV. Glucagon-like peptide-1 (GLP-1) Receptor Agonists
V. Thiazolidinediones
VI. DPP-4 Inhibitors
VII. Alpha Glucosidase Inhibitors
VIII. Others
B. Route of Administration
I. Oral
II. Injectables
C. Distribution Channel
I. Hospital Pharmacies
II. Retail Pharmacies
III. Online
IV. Others
5. Type Ⅱ Diabetes Mellitus Major Drugs Market Share………………………
A. Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape………………………………………………………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles…………………………………………………………………
A. Novo-Nordisk Company overview, Product & Services, Strategies & Financials
B. Sanofi (SA) Company overview, Product & Services, Strategies & Financials
C. Merck & Co. Company, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape…………………………………
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth………………………………………………………..
A. New Trends and Development of Type Ⅱ Diabetes Mellitus drug market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Drug Class:

On the basis of drug class, drugs are classified into Biguanides, Sulfonylureas, Meglitinides and glucagon-like peptide-1 (GLP-1) receptor agonists, D-Phenylalanine Derivatives, Thiazolidinediones, DPP-4 Inhibitors, Alpha-glucosidase Inhibitors, Bile Acid Sequestrants and Others

By Route of Administration:

On the basis of route of administration, the market can be segmented into Oral and Injectables.

Injectable drugs are further classified into Insulin, Exenatide, Liragultide and Pramlintide.

By Distribution Channel:

On the basis of distribution channel, the market for Type Diabetes Mellitus drugs can be segmented into hospital pharmacies, retail pharmacies, online pharmacies, and others.

Retail pharmacy segment holds the dominant share and is projected to high growth rates throughout the forecast period.

Major Players

Novo Nordisk has partnered with the Ministry of Health, Kenya to increase access of diabetes care in the country.

Merck & Co. is leading the diabetic drug segment with its drug, Glucophage (Metformin) which accounts for 19.8 % of all the oral hypoglycemic tablets sold.

Other companies like Sanofi (SA), Eli-Lilly, Boehringer Ingelheim, Bayer and Novartis are also major players in the industry.

Boehringer Ingelheim, one of the leading pharmaceutical companies, has introduced Trajenta, a new oral drug for the management of typeⅡdiabetes in Kenya.

Local pharmaceutical companies operating in Kenya are Dawa Limited, Didy Pharmaceuticals, Beta healthcare and Universal Pharmaceutical Limited.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements